Last week global stocks were positive, while the equity market tried to balance out encouraging vaccine news against ever-growing economic restrictions amid rising virus cases. During the last two weeks, stocks faced what we call a “rotation”, i.e. a change in leadership across asset classes, after Pfizer’s vaccine announcement on 11/9, followed by Moderna’s,
and again Pfizer’s giving an update regarding its last stage trial, and as investors’ sentiment and confidence about next year’s outlook improved….
